Ionic Liquids in Pharmaceutical Industry
Julia L. Shamshina,Paula Berton,Hui Wang,Xiaosi Zhou,Gabriela Gurau,Robin D. Rogers
DOI: https://doi.org/10.1002/9781119288152.ch20
2018-01-01
Abstract:Chapter 20 Ionic Liquids in Pharmaceutical Industry Julia L. Shamshina, Julia L. Shamshina 525 Solutions, Inc., Tuscaloosa, Alabama, USASearch for more papers by this authorPaula Berton, Paula Berton McGill University, Montreal, Department of Chemistry, Quebec, CanadaSearch for more papers by this authorHui Wang, Hui Wang Chinese Academy of Sciences, Institute of Process Engineering, Beijing, ChinaSearch for more papers by this authorXiaosi Zhou, Xiaosi Zhou Nanjing Normal University, Jiangsu Key Laboratory of Biofunctional Materials, School of Chemistry and Material Science, Nanjing, ChinaSearch for more papers by this authorGabriela Gurau, Gabriela Gurau 525 Solutions, Inc., Tuscaloosa, Alabama, USASearch for more papers by this authorRobin D. Rogers, Robin D. Rogers 525 Solutions, Inc., Tuscaloosa, Alabama, USA McGill University, Montreal, Department of Chemistry, Quebec, CanadaSearch for more papers by this author Julia L. Shamshina, Julia L. Shamshina 525 Solutions, Inc., Tuscaloosa, Alabama, USASearch for more papers by this authorPaula Berton, Paula Berton McGill University, Montreal, Department of Chemistry, Quebec, CanadaSearch for more papers by this authorHui Wang, Hui Wang Chinese Academy of Sciences, Institute of Process Engineering, Beijing, ChinaSearch for more papers by this authorXiaosi Zhou, Xiaosi Zhou Nanjing Normal University, Jiangsu Key Laboratory of Biofunctional Materials, School of Chemistry and Material Science, Nanjing, ChinaSearch for more papers by this authorGabriela Gurau, Gabriela Gurau 525 Solutions, Inc., Tuscaloosa, Alabama, USASearch for more papers by this authorRobin D. Rogers, Robin D. Rogers 525 Solutions, Inc., Tuscaloosa, Alabama, USA McGill University, Montreal, Department of Chemistry, Quebec, CanadaSearch for more papers by this author Book Editor(s):Wei Zhang, Wei ZhangSearch for more papers by this authorBerkeley W. Cue, Berkeley W. CueSearch for more papers by this author First published: 22 January 2018 https://doi.org/10.1002/9781119288152.ch20Citations: 16 AboutPDFPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShareShare a linkShare onFacebookTwitterLinked InRedditWechat Abstract This chapter reviews the roles of ionic liquids (ILs) in pharmaceutical manufacturing processes, including the use of ILs as solvents in the synthesis of drugs or isolation of drug intermediates, the use of ILs in pharmaceutical crystallization, in pharmaceutical separation, for the extraction of drugs from natural products, to deliver drugs, to detect drugs, and even as active pharmaceutical ingredients (APIs). ILs have also been considered as alternatives to organic solvents in the pharmaceutical industry. A large volume of volatile organic solvents (VOCs) is used in the process of drug extraction from natural products, resulting in serious environmental problems and replacement of conventional solvents by ILs might prevent the emission of VOCs. While ILs have been shown to be efficient vehicles in transdermal drug delivery, until recently they were not studied as transdermal drugs themselves because ionized salts normally diffuse poorly through lipid membranes. Citing Literature Green Techniques for Organic Synthesis and Medicinal Chemistry, Second Edition RelatedInformation